Molecular characterization of multidrug resistant Enterobacterales strains isolated from liver and kidney transplant recipients in Spain

Sci Rep. 2021 Jun 4;11(1):11875. doi: 10.1038/s41598-021-90382-5.

Abstract

The objective of this study was to analyse the mechanisms of resistance to carbapenems and other extended-spectrum-β-lactams and to determine the genetic relatedness of multidrug-resistant Enterobacterales (MDR-E) causing colonization or infection in solid-organ transplantation (SOT) recipients. Prospective cohort study in kidney (n = 142), liver (n = 98) or kidney/pancreas (n = 7) transplant recipients between 2014 and 2018 in seven Spanish hospitals. We included 531 MDR-E isolates from rectal swabs obtained before transplantation and weekly for 4-6 weeks after the procedure and 10 MDR-E from clinical samples related to an infection. Overall, 46.2% Escherichia coli, 35.3% Klebsiella pneumoniae, 6.5% Enterobacter cloacae, 6.3% Citrobacter freundii and 5.7% other species were isolated. The number of patients with MDR-E colonization post-transplantation (176; 71.3%) was 2.5-fold the number of patients colonized pre-transplantation (71; 28.7%). Extended-spectrum β-lactamases (ESBLs) and carbapenemases were detected in 78.0% and 21.1% of MDR-E isolates respectively. In nine of the 247 (3.6%) transplant patients, the microorganism causing an infection was the same strain previously cultured from surveillance rectal swabs. In our study we have observed a low rate of MDR-E infection in colonized patients 4-6 weeks post-transplantation. E. coli producing blaCTX-M-G1 and K. pneumoniae harbouring blaOXA-48 alone or with blaCTX-M-G1 were the most prevalent MDR-E colonization strains in SOT recipients.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Infections / complications*
  • Bacterial Infections / drug therapy*
  • Carbapenems / pharmacology*
  • Citrobacter freundii / drug effects*
  • Citrobacter freundii / genetics
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Enterobacter cloacae / drug effects*
  • Enterobacter cloacae / genetics
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / isolation & purification
  • Escherichia coli / drug effects*
  • Escherichia coli / genetics
  • Humans
  • Kidney Transplantation / adverse effects
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / isolation & purification
  • Liver Transplantation / adverse effects
  • Microbial Sensitivity Tests
  • Pancreas Transplantation / adverse effects
  • Prevalence
  • Prospective Studies
  • Spain / epidemiology
  • Transplant Recipients*

Substances

  • Anti-Bacterial Agents
  • Carbapenems